Melia Coratti Kramer, CNM | |
2151 E 14 Mile Rd Ste 200, Birmingham, MI 48009-7260 | |
(877) 648-7333 | |
Not Available |
Full Name | Melia Coratti Kramer |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 2151 E 14 Mile Rd Ste 200, Birmingham, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1972357416 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Melia Coratti Kramer, CNM 2466 Dorchester Rd, Birmingham, MI 48009-7407 Ph: (213) 422-5762 | Melia Coratti Kramer, CNM 2151 E 14 Mile Rd Ste 200, Birmingham, MI 48009-7260 Ph: (877) 648-7333 |
News Archive
A group of Massachusetts General Hospital investigators is proposing that targeting immune checkpoints - molecules that regulate the activity of the immune system - in immune cells called microglia could reduce the inflammatory aspects of important neurodegenerative diseases like Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
Already in 2014, the German Institute for Quality and Efficiency in Health Care examined in an early benefit assessment whether idelalisib offers advantages over the appropriate comparator therapy for patients with chronic lymphocytic leukaemia (CLL).
Netflix binge-watching versus a hike in the woods. A cheeseburger versus kale salad. Fentanyl versus Tylenol. New UC research from the University California, Berkeley, suggests our brain activity could be influenced to make the healthier choice.
A new study led by researchers at the Graduate Entry Medical School, University of Limerick has found that people with low levels and very high levels of a commonly measured laboratory test, the "transferrin saturation ratio" are at an increased risk of death. The test is a measure of the amount of available iron in the bloodstream with low levels generally reflecting a state of iron deficiency and high levels suggesting a relative excess.
Many modern cancer drugs target a specific genetic mutation that is driving a particular cancer's runaway growth and division - such as the HER-2 protein in some breast cancers or EGFR in certain lung cancers.
› Verified 4 days ago